Video
ARVO LIVE: OTT166 in the treatment of diabetic retinopathy
Author(s):
Ophthalmology Times® talked with David Tanzer, MD, about OcuTerra Therapeutics and their development of OTT166 in the treatment of diabetic retinopathy.
Ophthalmology Times® talked with David Tanzer, MD, about OcuTerra Therapeutics and their development of OTT166 in the treatment of diabetic retinopathy.
Video transcript
Editor’s note: Transcript lightly edited for clarity.
Related Videos
Related Content
Published: October 9th 2024 | Updated: October 9th 2024
